Gene Information
|
Gene Name
|
ANXA2 |
|
Gene ID
|
302
|
|
Gene Full Name
|
annexin A2 |
|
Gene Alias
|
ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV |
|
Transcripts
|
ENSG00000182718
|
|
Virus
|
HEV |
|
Gene Type
|
protein-coding |
|
HPA Location Info
|
Plasma membrane;Cytosol;Secreted to blood;
|
|
Membrane Info
|
Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters |
|
Uniport_ID
|
P07355
|
|
HGNC ID
|
HGNC:537
|
|
OMIM ID
|
151740 |
|
Summary
|
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions as an autocrine factor which heightens osteoclast formation and bone resorption. This gene has three pseudogenes located on chromosomes 4, 9 and 10, respectively. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. Annexin A2 expression has been found to correlate with resistance to treatment against various cancer forms. [provided by RefSeq, Dec 2019] |
Target gene [ANXA2] related to virus gene/protein/region
Mutation Table: if previous studies reported that target gene was related to virus gene/region/protein, the information in this literature was listed in this section
Target gene [ANXA2] related to Omics data
| Data ID |
Experiment type |
Sample number |
Platform |
|
GSE262469
|
RNA-seq |
15 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
GSE251924
|
RNA-seq |
6 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
GSE274780
|
RNA-seq |
12 |
Illumina NextSeq 500 (Homo sapiens) |
|
|